109 related articles for article (PubMed ID: 10623685)
1. Experimental models of prostate cancer research.
Cohen MB; Padarathsingh M; Hendrix MJ
Am J Pathol; 2000 Jan; 156(1):355-8. PubMed ID: 10623685
[No Abstract] [Full Text] [Related]
2. Prostate cancer progression. Implications of histopathology.
Ware JL
Am J Pathol; 1994 Nov; 145(5):983-93. PubMed ID: 7977655
[TBL] [Abstract][Full Text] [Related]
3. [Anti-apoptotic effect of the androgen receptor in human prostate cancer].
Shen FY; Li BY
Zhonghua Nan Ke Xue; 2007 Dec; 13(12):1121-4. PubMed ID: 18284065
[TBL] [Abstract][Full Text] [Related]
4. Conference summary: First International Workshop on Animal models of Prostate Cancer.
Waters DJ; Bostwick DG; Murphy GP
Prostate; 1998 Jun; 36(1):47-8. PubMed ID: 9650915
[No Abstract] [Full Text] [Related]
5. Environmental, genetic, and molecular features of prostate cancer.
Deutsch E; Maggiorella L; Eschwege P; Bourhis J; Soria JC; Abdulkarim B
Lancet Oncol; 2004 May; 5(5):303-13. PubMed ID: 15120667
[TBL] [Abstract][Full Text] [Related]
6. Molecular biology of prostate cancer.
Karayi MK; Markham AF
Prostate Cancer Prostatic Dis; 2004; 7(1):6-20. PubMed ID: 14999233
[TBL] [Abstract][Full Text] [Related]
7. Exploiting the complex biology of prostate cancer.
Thompson TC
Cancer Biol Ther; 2006 Nov; 5(11):1573-6. PubMed ID: 17172813
[No Abstract] [Full Text] [Related]
8. Par-4 inducible apoptosis in prostate cancer cells.
Gurumurthy S; Rangnekar VM
J Cell Biochem; 2004 Feb; 91(3):504-12. PubMed ID: 14755681
[TBL] [Abstract][Full Text] [Related]
9. miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer.
Cai C; Chen QB; Han ZD; Zhang YQ; He HC; Chen JH; Chen YR; Yang SB; Wu YD; Zeng YR; Qin GQ; Liang YX; Dai QS; Jiang FN; Wu SL; Zeng GH; Zhong WD; Wu CL
Clin Cancer Res; 2015 Nov; 21(21):4922-34. PubMed ID: 26080838
[TBL] [Abstract][Full Text] [Related]
10. Methylation of apoptosis related genes in the pathogenesis and prognosis of prostate cancer.
Suzuki M; Shigematsu H; Shivapurkar N; Reddy J; Miyajima K; Takahashi T; Gazdar AF; Frenkel EP
Cancer Lett; 2006 Oct; 242(2):222-30. PubMed ID: 16458425
[TBL] [Abstract][Full Text] [Related]
11. LncRNA PVT1 predicts prognosis and regulates tumor growth in prostate cancer.
Yang J; Li C; Mudd A; Gu X
Biosci Biotechnol Biochem; 2017 Dec; 81(12):2301-2306. PubMed ID: 29050519
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer: towards the standardization and synthesis of morphology, genetics, and prognosis.
Berney D; Cheng L
Histopathology; 2012 Jan; 60(1):1-3. PubMed ID: 22212074
[TBL] [Abstract][Full Text] [Related]
13. Models for prostate cancer.
Prog Clin Biol Res; 1980; 37():1-397. PubMed ID: 7384080
[No Abstract] [Full Text] [Related]
14. Overexpression of cyclooxygenase-2 in human prostate carcinoma and prostatic intraepithelial neoplasia-association with increased expression of Polo-like kinase-1.
Denkert C; Thoma A; Niesporek S; Weichert W; Koch I; Noske A; Schicktanz H; Burkhardt M; Jung K; Dietel M; Kristiansen G
Prostate; 2007 Mar; 67(4):361-9. PubMed ID: 17265445
[TBL] [Abstract][Full Text] [Related]
15. Small G-protein RhoE is underexpressed in prostate cancer and induces cell cycle arrest and apoptosis.
Bektic J; Pfeil K; Berger AP; Ramoner R; Pelzer A; Schäfer G; Kofler K; Bartsch G; Klocker H
Prostate; 2005 Sep; 64(4):332-40. PubMed ID: 15754346
[TBL] [Abstract][Full Text] [Related]
16. Castration induces apoptosis in the ventral prostate but not in an androgen-sensitive prostatic adenocarcinoma in the rat.
Brändström A; Westin P; Bergh A; Cajander S; Damber JE
Cancer Res; 1994 Jul; 54(13):3594-601. PubMed ID: 8012987
[TBL] [Abstract][Full Text] [Related]
17. [Hormonal and molecular biological factors in pathogenesis of prostate cancer].
Zezerov EG
Vopr Onkol; 2001; 47(2):174-81. PubMed ID: 11383453
[TBL] [Abstract][Full Text] [Related]
18. Huntingtin-interacting protein 1 is overexpressed in prostate and colon cancer and is critical for cellular survival.
Rao DS; Hyun TS; Kumar PD; Mizukami IF; Rubin MA; Lucas PC; Sanda MG; Ross TS
J Clin Invest; 2002 Aug; 110(3):351-60. PubMed ID: 12163454
[TBL] [Abstract][Full Text] [Related]
19. Unopposed c-MYC expression in benign prostatic epithelium causes a cancer phenotype.
Williams K; Fernandez S; Stien X; Ishii K; Love HD; Lau YF; Roberts RL; Hayward SW
Prostate; 2005 Jun; 63(4):369-84. PubMed ID: 15937962
[TBL] [Abstract][Full Text] [Related]
20. Sensitivity of prostate cells to TRAIL-induced apoptosis increases with tumor progression: DR5 and caspase 8 are key players.
Hesry V; Piquet-Pellorce C; Travert M; Donaghy L; Jégou B; Patard JJ; Guillaudeux T
Prostate; 2006 Jun; 66(9):987-95. PubMed ID: 16541419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
